Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kuma, Akihiro ^a   Yamada, Sohsuke ^a   Wang, Ke Yong ^b   Kitamura, Noriaki ^a   Yamaguchi, Takahiro ^a   Iwai, Yoshiko ^a   Izumi, Hiroto ^a   Tamura, Masahito ^a   Otsuji, Yutaka ^a   Kohno, Kimitoshi ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 4; PEROXIREDOXIN 5; WNT1 PROTEIN; WNT10A PROTEIN; WNT3 PROTEIN; WNT4 PROTEIN; ACTA2 PROTEIN, HUMAN; ACTIN; WNT PROTEIN; WNT10A PROTEIN, HUMAN;

AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FIBROBLAST; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ACUTE DISEASE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ACTINS; ACUTE DISEASE; AGED; APOPTOSIS; FIBROBLASTS; FIBRONECTINS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MALE; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS; WNT PROTEINS;

EID: 84904684085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103240     Document Type: Article

References (47)

1. Eddy AA (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301.
2. Liu Y (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217.
3. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18: 1028-1040.
4. Moon RT, Kohn AD, De Ferrari GV, Kaykas A (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701. (Pubitemid 39150127)
5. Kohn AD, Moon RT (2005) Wnt and calcium signaling: beta-catenin- independent pathways. Cell Calcium 38: 439-446. (Pubitemid 41283282)
6. Carroll TJ, Das A (2011) Planar cell polarity in kidney development and disease. Organogenesis 7: 180-190.
7. Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15: 28-32.
8. He W, Dai C, Li Y, Zeng G, Monga SP, et al. (2009) Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776.
9. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, et al. (2009) Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008.
10. Yasuniwa Y, Izumi H, Wang KY, Shimajiri S, Sasaguri Y, et al. (2010) Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway. PLoS One 5: e15330.
11. Grande MT, López-Novoa JM (2009) Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 5: 319-328.
12. Kitada S, Yamada S, Kuma A, Ouchi S, Tasaki T, et al. (2013) Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumors and poor prognosis in patients with renal cell carcinomas. Br J Cancer 109: 472-481.
13. Noguchi H, Yamada S, Nabeshima A, Guo X, Tanimoto A, et al. (2014) Depletion of apoptosis signal-regulating kinase 1 prevents bile duct ligation-induced necroinflammation and subsequent peribiliary fibrosis. Am J Pathol 184: 644-661.
14. Igarashi T, Izumi H, Uchiumi T, Nishio K, Arao T, et al. (2007) Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 26: 4749-4760. (Pubitemid 47093179)
15. Shiota M, Izumi H, Miyamoto N, Onitsuka T, Kashiwagi E, et al. (2008) Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci 99: 1950-1959.
16. Miyamoto N, Izumi H, Noguchi T, Nakajima Y, Ohmiya Y, et al. (2008) Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance. J Biol Chem 283: 18218-18226.
17. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, et al. (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102: 1007-1013.
18. Wakasugi T, Izumi H, Uchiumi T, Suzuki H, Arao T, et al. (2007) ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes. Oncogene 26: 5194-5203. (Pubitemid 47237622)
19. Miyamoto N, Izumi H, Miyamoto R, Kubota T, Tawara A, et al. (2009) Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress. Invest Ophthalmol Vis Sci 50: 2777-2784.
20. Sedeek M, Callera G, Montezano A, Gutsol A, Heitz F, et al. (2010) Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol 299: F1348-1358.
21. Joshi S, Peck AB, Khan SR (2013) NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys. Oxid Med Cell Longev 2013: 462361.
22. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, et al. (2012) Recent developments in myofiroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180: 1340-1355.
23. Kawakami T, Ren S, Duffield JS (2013) Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol 229: 221-231.
24. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363. (Pubitemid 34619269)
25. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, et al. (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19: 1047-1053.
26. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, et al. (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97.
27. Zeisberg M, Kalluri R (2004) The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) 82: 175-181. (Pubitemid 38392167)
28. El Kahi CG, Atiyeh BS, Abdallah Hajj Hussein I, Jurjus R, Dibo SA, et al. (2009) Modulation of wound contracture alpha-smooth muscle actin and multispecific vitronectin receptor integrin alphavbeta3 in the rabbit's experimental model. Int Wound J 6: 214-224.
29. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C (2001) Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12: 2730-2741. (Pubitemid 33051938)
30. Wei J, Melichian D, Komura K, Hinchcliff M, Lam AP, et al. (2011) Canonical Wnt signaling induces skin fibrosis and subcutaneous lipotrophy: a novel mouse model for scleroderma? Arthritis Rheum 63: 1707-1717.
31. Surendran K, Schiavi S, Hruska KA (2005) Wnt-dependent β-catenin signaling is activated after unilateral ureteral obstraction, and recombinant secreted fizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16: 2373-2384. (Pubitemid 41725055)
32. Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18: 816-827.
33. Mao Y, Schwarzbauer JE (2005) Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24: 389-399. (Pubitemid 41765018)
34. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503.
35. Song KS, Kim HK, Shim W, Jee SH (2001) Plasma fibronectin levels in ischemic heart disease. Atherosclerosis 154: 449-453. (Pubitemid 32146618)
36. Claudepierre P, Allanore Y, Belec L, Larget-Piet B, Zardi L, et al. (1999) Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population. Rheumatology (Oxford) 38: 1099-1103. (Pubitemid 29537330)
37. Heise RL, Stober V, Cheluvaraju C, Hollingsworth JW, Garantziotis S (2011) Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J Biol Chem 286: 17435-17444.
38. Chen JH, Chen WL, Sider KL, Yip CY, Simmons CA (2011) β-catenin medicates mechanically regulated, transforming growth factor-β1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol 31: 590-597.
39. Wood ZA, Schröder E, Robin Harris J, Poole LB (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40. (Pubitemid 36051004)
40. Oláhová M, Taylor SR, Khazaipoul S, Wang J, Morgan BA, et al. (2008) A redox-sensitive peroxiredoxin that is important for longevity has tissue- and stress-specific roles in stress resistance. Proc Natl Acad Sci U S A 105: 19839-19844.
41. Liu J, Jiang Y, Mao J, Gu B, Liu H, et al. (2013) High levels of glucose induces a dose-dependent apoptosis in human periodontal ligament fibroblasts by activating caspase-3 signaling pathway. Appl Biochem Biotechnol 170: 1458-1471.
42. Gianella A, Nobili E, Abbate M, Zoja C, Gelosa P, et al. (2007) Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am J Pathol 170: 1165-1177. (Pubitemid 47339325)
43. Vieira JM Jr, Mantovani E, Rodrigues LT, Dellê H, Noronha IL, et al. (2005) Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 20: 1582-1591. (Pubitemid 41418580)
44. Schaafsma D, McNeill KD, Mutawe MM, Mutawe MM, Ghavami S, et al. (2011) Simvastatin inhibits TGFβ1-induced fibronectins in human airway fibroblasts. Respir Res 12: 113.
45. Bereswill S, Muñoz M, Fischer A, Plickert R, Haag LM, et al. (2010) Antiinflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5: e15099.
46. Yagi H, Kato T, Nagata T, Habu T, Nozaki M, et al. (1995) Regulation of the mouse histone H2A.X gene promoter by the transcription factor E2F and CCAAT binding protein. J Biol Chem 270: 18759-18765.
47. Javanmoghadam-Kamrani S, Keyomarsi K (2008) Synchronization of the cell cycle using lovastatin. Cell Cycle 7: 2434-2440.